At TEDMED last week we spoke with Rich Noffsinger, CEO of Anvita Health. Today Anvita has announced a new method of providing point-of-care drug decision assistance utilizing a patient’s own EMR data coupled with findings from comparative effectiveness research.
The patent, issued earlier this month, uses a computerized indexing system integrating several databases to rank and sort available drugs to treat a given diagnosis. Ranking and sorting the drugs is conducted within the context of an individual patient’s medical history based upon data extracted from medical claims, pharmacy claims, lab values, electronic medical records, and any other available clinical data.
Using evidence-based rules, including rules based upon the findings of Patient-Centered Outcomes Research, also known as comparative effectiveness research, total efficacy of drug regimens is analyzed, and the results may be output or displayed in a variety of ways for use by the health care provider.